We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$230B
AUM Growth
+$18.4B
Cap. Flow
-$8.18B
Cap. Flow %
-3.55%
Top 10 Hldgs %
23.04%
Holding
10,299
New
1,220
Increased
3,476
Reduced
4,117
Closed
1,266

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$615M
2
UBER icon
Uber
UBER
+$551M
3
EXPE icon
Expedia Group
EXPE
+$523M
4
PYPL icon
PayPal
PYPL
+$452M
5
ETN icon
Eaton
ETN
+$408M

Sector Composition

Rank Sector Weight
1 Technology 5.29%
2 Financials 4.55%
3 Industrials 4.18%
4 Healthcare 4.08%
5 Consumer Discretionary 3.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZN
8826
CALL
DELISTED
Zion Oil & Gas, Inc.
ZN
$10K ﹤0.01%
58,400
-3,600
-6% -$703
IGC icon
8827
IGC Pharma
IGC
$30.4M
$9K ﹤0.01%
14,735
-27,496
-65% -$22.5K
UAVS icon
8828
AgEagle Aerial Systems
UAVS
$64.5M
$9K ﹤0.01%
+20
New +$8.92K
NVIV
8829
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$9K ﹤0.01%
+55
New +$13.7K
BKYI
8830
BIO-key International
BKYI
$3.29M
$8K ﹤0.01%
12
-35
-74% -$28.5K
TKAT
8831
DELISTED
Takung Art Co., Ltd.
TKAT
$8K ﹤0.01%
15,057
-24,119
-62% -$12.4K
AMPE
8832
PUT
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$8K ﹤0.01%
47
-1
-2% -$129
GPL
8833
CALL
DELISTED
Great Panther Mining Limited
GPL
$8K ﹤0.01%
1,560
-3,490
-69% -$18.4K
KOPN icon
8834
CALL
Kopin
KOPN
$983M
$7K ﹤0.01%
18,200
+3,700
+26% +$1.9K
TAOP icon
8835
Taoping
TAOP
$8.94M
$7K ﹤0.01%
7
+1
+17% +$931
VIRX
8836
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$7K ﹤0.01%
629
-551
-47% -$9.23K
CPHI icon
8837
China Pharma Holdings
CPHI
$43M
$6K ﹤0.01%
52
-147
-74% -$18.1K
VIRX
8838
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$6K ﹤0.01%
477
-103
-18% -$1.73K
VIRX
8839
PUT
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$5K ﹤0.01%
383
IZEA icon
8840
IZEA Worldwide
IZEA
$53.6M
$3K ﹤0.01%
+3,467
New +$3.65K
BSIN
8841
Big Sky Industrial
BSIN
$72.4M
$3K ﹤0.01%
1,141
-608
-35% -$2.39K
ZN
8842
PUT
DELISTED
Zion Oil & Gas, Inc.
ZN
$3K ﹤0.01%
16,400
-600
-4% -$117
AAXJ icon
8843
PUT
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.86B
-5,700
Closed -$378K
ABCB icon
8844
Ameris Bancorp
ABCB
$5.94B
-10,100
Closed -$431K
ABCB icon
8845
PUT
Ameris Bancorp
ABCB
$5.94B
-9,000
Closed -$362K
ABEV icon
8846
PUT
Ambev
ABEV
$43B
-73,800
Closed -$341K
ACIW icon
8847
CALL
ACI Worldwide
ACIW
$5.38B
-6,800
Closed -$213K
ACN icon
8848
Accenture
ACN
$108B
-6,042
Closed -$1.18M
ACSI icon
8849
American Customer Satisfaction ETF
ACSI
$119M
-5,959
Closed -$203K
ADAP
8850
DELISTED
Adaptimmune Therapeutics
ADAP
-18,962
Closed -$29K

Similar funds

Ken Griffin's Q4 2019 Portfolio in Review

As of Q4 2019, Ken Griffin held 10,299 positions worth $230B, up 8.7% from $212B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ken Griffin withdrew a net $8.18B in Q4 2019, closing 1,266 positions and reducing 4,117 holdings. Its most notable exit was Celgene Corp, an estimated $681M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.3% of assets, down from 5.4% a quarter earlier, followed by Financials and Industrials.

Against the trend, Ken Griffin opened a new position in Interxion Holding N.V. worth $83.9M.

  • Ken Griffin's largest Q4 2019 buy was Interxion Holding N.V.: 1,000,931 shares worth $83.9M.
  • Ken Griffin added most to Amazon in Q4 2019, an estimated $615M increase.
  • Ken Griffin's biggest Q4 2019 reduction was Raytheon Company, cutting an estimated $543M.
  • Ken Griffin fully exited Celgene Corp in Q4 2019, selling an estimated $681M.
  • Ken Griffin's ten largest holdings make up 23% of its $230B portfolio in Q4 2019.
  • Ken Griffin opened 1,220 new positions and closed 1,266 in Q4 2019.
  • Ken Griffin's portfolio value rose 8.7% quarter-over-quarter to $230B.

Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.